Skip to main
INDV
INDV logo

Indivior PLC (INDV) Stock Forecast & Price Target

Indivior PLC (INDV) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Indivior PLC has raised its 2025 revenue guidance for Sublocade to a range of $765 million to $786 million, indicating positive momentum due to continued volume growth and targeted efforts in the Medicaid and commercial patient segments. The company stands as a leader in the treatment of substance use disorders, poised to capitalize on the increasing adoption of Medication-Assisted Treatments (MATs) amid growing public awareness and diminishing stigma surrounding addiction treatment. Furthermore, while competitors like Brixadi have gained market share, Sublocade's market share has stabilized, reinforcing Indivior's strong position in a growing market.

Bears say

Indivior PLC faces significant revenue challenges as the decline in Suboxone sales, attributed to increasing generic competition, is expected to continue, raising concerns about the company's overall financial stability. Although Sublocade shows potential for growth in the long-acting injectable (LAI) category, it is still early in its commercial lifecycle and may not sufficiently counterbalance the ongoing Suboxone revenue erosion. Furthermore, the projected increase in selling, general and administrative (SG&A) expenses to 45% of revenue in 2026, while a slight improvement from 2025, indicates persistent operational cost challenges that could further impact profitability.

Indivior PLC (INDV) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Indivior PLC and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Indivior PLC (INDV) Forecast

Analysts have given Indivior PLC (INDV) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Indivior PLC (INDV) has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Indivior PLC (INDV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.